A Comprehensive review on Anthelminthics

Edarada Kavya Anisha*, Gangapatrula Hema Sudha, Dongala Kanakamahalakshmi, Pasumarthi Phaneendra

Vikas Institute of Pharmaceutical sciences, Rajahmundry.

*Correspondence: anishaedarada.11@gmail.com ,Tel.: 8125464130

DOI: https://doi.org/10.71431/IJRPAS.2025.4402

INTRODUCTION

Helminths are worms that cause significant health issues in animals worldwide. Despite controlling pastures, these methods are insufficient for eliminating these parasites. Pharmaceutical anthelmintics are the primary method for controlling helminthiasis, which accounts for a significant portion of animal health expenditure in many countries.[1] Gastrointestinal nematodes (GINs) are prevalent in developing countries, particularly in small ruminant goats. Haemonchus contortus, a pathogenic species, causes severe anaemia and anasarca, leading to acute mortality. It's prevalent in tropical climates like the Philippines, causing production losses, high neonatal mortality, all-age morbidity, and high treatment costs, hindering the development of small ruminant subsectors.[2] Common and persistent parasitic nematodes infect humans include roundworms, whipworms, hookworms, threadworms, filarial nematodes responsible for lymphatic filariasis, and onchocerciasis. Tapeworms like Taenia Solium, Taenia saginata, Hymenolepis nana, and Dipylidium caninum also affect humans.[6]

Malnutrition and intestinal parasitic infections (IPIs) are prevalent public health issues in children in developing countries, causing thousands of avoidable deaths annually. IPIs are the leading cause of illness and disease globally. Preschool and school-aged children, including adolescents, are more likely to harbour the most intestinal worms, leading to growth stunting, physical fitness decline, and impaired memory and cognition. These health issues impair educational performance, reduce school attendance, and potentially reduce future wage-earning capacity. Even mild to moderate-intensity helminth infections during childhood have been linked to undernutrition and reduced physical fitness.[3]

Since ancient times, people have sought natural remedies for diseases. The use of medicinal plants was instinctive, based on experience and lack of information about which plants could be used. As the reasons for specific plant treatments became known, the use of medicinal plants gradually abandoned the empiric framework and became based on explicatory facts. Until the 16th century, plants were the primary source of treatment and prophylaxis, as explained by iatrochemistry. Medicinal plants are essential for primary health care, treating diseases and injuries. They are traditionally used in foods, drinks, herbs, and spices. The widespread use of traditional medicine is attributed to its cultural acceptability, economic affordability, and efficacy against certain diseases. Indigenous communities worldwide have diverse experiences in various medicinal plants, using their perceptions to categorize plants and parts for various ailments.[4]

The treatment of haemonchosis heavily relies on commercial and synthetic anthelmintics like albendazole and ivermectin, leading to the term 'global worming'. However, this has led to an increase in anthelmintic-resistant GINs, particularly H. contortus. These parasites have specific anthelmintic genes that allow them to persist and cause harm. The slow commercialization of novel anthelmintic compounds has worsened anthelmintic resistance, particularly in goat farms. Commercial and synthetic anthelmintics pose a threat to public health and sustainability in developing countries due to their indiscriminate application, increasing drug residues in milk and meat, and questionable sustainability in ruminant farming. To combat these issues, new approaches are being explored, such as screening plants for novel anthelmintic compounds,

which could help combat GINs and promote sustainable livestock farming. Anthelmintics from indigenous plants are beneficial for small and large farmers transitioning to organic farming. They are eco-friendly and biodegradable, and their bioactive compounds may kill parasites multiple times, reducing the risk of developing anthelmintic resistance. These natural products are less likely to bioaccumulate in animal and environmental tissues, making them a practical choice for small and large farmers.[2] Anthelmintic discovery and development are influenced by a wide range of factors, procedures, and obstacles. To increase potency, safety, pharmacokinetics, pharmacodynamics, and formulation, a chemical (or class) will usually go through many rounds of optimization. Regulatory requirements require that the production process be created, cost-effectively optimized, and strictly regulated. Lastly, a medication needs to clear the regulatory requirements for both registration and continuous pharmacovigilance.[16]

Protein and nutrient loss from hookworm infections can result in malabsorption and worsen nutritional deficiencies. Iron shortage can result from micro bleeding at nematode attachment sites, particularly in populations with insufficient iron consumption. Co-infection with malaria or other STHs can worsen the relationship between moderate to severe hookworm infections and anaemia, iron deficiency anaemia, and low haemoglobin.[5] Treating human and animal health issues has been greatly aided by traditional medicine. The health benefits of plants Care continues to be the primary alternative treatment for a variety of illnesses in the nation. This is mostly caused by a lack of pharmaceutical products, the prohibitive distance between health service stations, the high cost of conventional drugs for small-holder farmers and pastoralists, the emergence and reemergence of specific diseases, and the emergence of Helminthes and/or drug-resistant microbes. In various regions of the nation, the plant is utilized to treat a variety of illnesses. Nonetheless, helminthic infections remain a serious health risk to people, particularly those residing in tropical developing nations.[4]

CLASSES OF ANTHELMINTIC AGENTS         

Anthelmintics are drugs used to treat parasitic worm infections without significant harm to the host, but pharmaceutical companies have made slow progress in drug discovery and development.[7] Anthelmintics are categorized by chemical structure and mode of action, with several main classes. A. some studies provide most information on physiological and pharmacological actions, while C. elegans helps define molecular targets.[8] Helminthes infections are prevalent worldwide, affecting large populations. Anthelmintics are widely used for treating parasitic diseases, but their use has recently been linked to human toxicity.[9]

Here the list of drugs.

Albendazole

Albendazole, a product of Smith-Kline-Beckman Corporation, is a methyl[5-(propylthio)-1-H-benzimidazol-2-yl] carbamate with chemical structures depicted in Fig. 1, which is almost insoluble in water and slightly soluble in most organic solvents.[10]

Mebendazole

Mebendazole, a benzimidazole derivative, exhibits anthelmintic activity by irreversibly inhibiting glucose uptake into nematodes, leading to glycogen depletion and decreased generation of A TP essential for survival and replication in parasites.[11]

Thiobendazole

Thiobendazole, an anthelmintic in the same series, inhibits fumarate reductase mechanisms but doesn't significantly affect worm glycogen content, suggesting structural modification increases anthelmintic activity and another mode of action.[11]

Flubendazole

Flubendazole, a p-fluoro derivative of mebendazole, is a methyl carbamate with a molecular weight of 3l3.29. It is insoluble in water and inorganic acids but slightly soluble in organic acids and solvents.[10]

Morantel

Morantel tartrate (Pfizer) is the 3-methyl derivative of pyrantel tartrate. The molecular weight of 1,4,5,6-tetrahydro-l-methyl-2-[2-(3-methyl-2-thienyl) ethenyl] pyrimidine is 220.3.[10]

Oxantel

Oxantel pamoate or 1-methyl-1,4,5,6-tetrahydro-2-(3-hydroxystyryl) pyrimidine pamoate (molecular weight, 604.67) is a light-yellow crystalline salt, practically insoluble in water. After oral administration oxantel pamoate is poorly absorbed so that high concentrations are reached in the cecum and colon.[10]

Pyrantel

As a pamoate salt (C34H30N 206S; molecular weight, 594.69; Pfizer), pyrantel ,1,4,5,6-tetrahydro-l-methyl-2-[2-(2-thienyl) vinyl pyrimidine (CllH14N2S; molecular weight, 206.3) is accessible. It is a yellow, crystalline powder with no taste that is nearly insoluble in water. It comes in tartrate form as well. (ClsH2oN206S; Pfizer; molecular weight, 392), which dissolves in water at a concentration of 180 mg/ml. In order to provide an anthelmintic that is poorly absorbed from the gut, pyrantel pamoate was manufactured. Blood levels are not greater than 1 Jlg/ml, and between 50% and 70% of the eaten amount is eliminated in the faeces.[10]

Ivermectin

Ivermectin is a semi-synthetic derivative derivative of avermectin, introduced as an anthelmintic in the 1980s by Merck. It contains a large macrocyclic lactone fermented product of Streptomyces avermitilis, a micro-organism. Ivermectin causes paralysis of pharyngeal and body wall muscles and interacts with various channels, including ligand-gated ion channels, acetylcholine-gated chloride channels, GABA-gated chloride channels, histamine-gated chloride channels, and glycine receptors. Nematode glutamate-gated chloride channels (GluCl) have high affinity and potent anthelmintic activity. The Merck team successfully expressed GluCl-α and GluCl-β ion channel subunits in C. elegans, with GluCl-α responding to micromolar quantities of ivermectin but not to glutamate, and GluCl-β responding to glutamate but not to ivermectin. GluCl-α subunits encode four genes in C. elegans, two of which are alternatively spliced. Ivermectin does not impair the anthelmintic effect of this medication against Ascaridia galli or its pharyngeal. In the motor nervous system, GluCl channels play a crucial role in modulating the paralytic effects of ivermectin by controlling glutamatergic behaviour and the amount of time forward motion lasts. Since large levels of resistance are necessary in mutations of these species, the mechanism behind ivermectin resistance in C. elegans has been thoroughly explored. It is less clear-cut and more debatable how GluCl mutations contribute to ivermectin resistance in the field.[9]

Piperazine

Piperazine, a popular and widely used drug for parasitic infection treatment, was first used as an anthelmintic in the 1950s. It is still used in over-the-counter remedies for thread worm infection in children. Its mode of action has been studied in A. suum, but no literature exists on its action in C. elegans. In A. suum, it acts as a weak GABA-mimetic agent, causing flaccid or reversible paralysis of body wall muscle.[9]

Tetramisole

Ascaris experiences increased muscular tone, followed by partial relaxation and irreversible paralysis. dl-Tetramisole reduces muscle cell belly membrane potential, as reported by ACEVES et al. in 1970. GAITONDE and MAHAJAN confirmed its depolarizing action, with dl-Tetramisole isomers stimulating ganglionic structures and inhibiting depolarizing neuromuscular type.[11]

Organophosphorus Compound

The Organophosphorus Substances have the capacity to function as cholinesterase inhibitors, making them insecticides. In sheep and cattle, some of them have been examined for anthelmintic action. Most of the compounds that were evaluated were shown to have anthelmintic action; nevertheless, their clinical usage is challenging due to their limited and uncertain margin of safety.[11]

Diethylcarbamazine

Diethylcarbamazine, which shares a tight chemical relationship with piperazine, improves the spontaneous activity and muscular tone of the nematode nerve muscle preparation while having no discernible impact on the muscle’s reaction to acetylcholine. Diethylcarbamazine's effect is not inhibited by d-tubocurarine, and it may even be enhanced. A newly developed anthelmintic called pyrantepamoate immobilizes worms by causing a neuromuscular blockade. Given that the neuromuscular system of the anthelmintics varies greatly from that of the host and from one helminth to another, it provides a range of weak areas for the development of novel, targeted medications.[11]

MECHANISM OF ACTION OF ANTHELMINTIC

Two primary sites of action are suggested by current understanding of anthelmintic mechanisms of action: (1) interference with energy-generating metabolism and (2) interference with neuromuscular transmission. When considering the target parasites, which are usually adult stage worms, these principles are not surprising. For reasons not discussed here, success in halting the life cycle at other stages (i.e., eggs, larvae) has been negligible until recently. Mature worms lack several life-supporting biochemical pathways that might be attacked by chemicals. Lipid metabolism doesn't seem to be a major function of adult helminths. They seldom ever produce cholesterol or sterols or oxidize lipids (aside from reversing oxidation to make volatile acids; Ward & Fairbairn, 1970). Fioravanti & MacInnis (1977) found that Hymenolepis diminuta could synthesis 2-trans and 6-trans farnesols, but not squalene. However, research by Jaffe, McCormack & Meymarian (1971), and Jaffe (1972) has shown that tubercidin, a nucleoside analogue, and suramin, which seems to be a dihydrofolate reductase inhibitor, are effective against Schistosoma and Onchocerca, respectively. These results imply that if generalizations about the lack of significance of nucleic acid metabolism are to be made, a more comprehensive knowledge of the process is required. Finally, although this does not explain the need for rapid protein synthesis for egg formation, it has not been shown that adult helminth survival needs protein synthesis in the near future. Maintaining a suitable feeding site and using the food to generate chemical life support energy provide the main basis for life-supporting functions. The breakdown of glucose is the main mechanism that generates energy (von Brand, 1973, p.96). Maintenance of the feeding site requires proper neuromuscular synchronization. Therefore, anthelmintic action usually stems from disturbance of one or both functions. The usefulness of these basic principles depends on the scope of the exceptions. If the life-support pathways in practically all worms were the same, anthelmintics should have a broad variety of uses; if life-support systems varied, it would be necessary to develop unique drugs for each worm.[12]

1.    Energy Metabolism

Recent developments in our knowledge of the biochemical mechanism of parasite energy metabolism serve as the foundation for biochemical approaches to anthelmintic mechanism of action clarification. The majority of parasitic helminths are mostly anaerobic. Their primary energy source, the metabolism of carbohydrates, is where they biochemically diverge from their vertebrate hosts. Glycogen has been identified as the primary endogenous carbohydrate among the many species that have been examined thus far. The majority of these species do not fully oxidize carbohydrates. Because of this kind of wasteful metabolism, organic acids are produced that the parasite cannot use and are released into the external media. In certain of their habitats, the worms appear to obtain all of their energy anaerobically, even in the presence of high oxygen levels. Nonetheless, it has been identified that some of the enzymatic processes may benefit greatly from the little quantities of oxygen that helminths typically absorb. It has been demonstrated that Ascaris uses an oxygen-dependent mechanism to create hydroxyproline, a component of nematode cuticle in the tum. The body's ability to metabolize carbohydrates may be impacted by anthelmintics in a number of ways, starting with the disruption of glucose absorption and moving on to the disruption of several enzyme pathways required for the burning of carbohydrates as fuel. Worms use carbohydrates in a different enzymatic pathway than their vertebrate hosts in a number of ways. Ascaris handles glucose differently than its mammalian host. Glycolytic enzymes convert carbohydrates to phosphoenolpyruvate (PEP) in the cytoplasm of both host and ascaris cells. Pyruvate kinase then catalyses the cytoplasmic synthesis of pyruvate in mammalian cells. Because Ascaris has low pyruvate kinase activity, it is unable to produce pyruvate from PEP. Oxalacetate is created when ascaris cells fix CO2 into PEP. Malate dehydrogenase activity causes the glycolytically generated DPNH to quickly diminish this. Consequently, malate that was created in the cytoplasm now enters the mitochondria. Malate undergoes oxidative decarboxylation, which produces pyruvate and CO2. The DPNH produced during this process helps to convert some of the malate to succinate by fumarate and the fumarate reductase reaction, which also produces ATP. Consequently, ascaris has several enzyme systems that differ from those of the host and might be targets of chemotherapeutic assault. Additional variations for a similar strategy may be found by examining the energy-producing metabolism of different helminths.[11]

Examples:

·      Albendazole is one of several benzimidazoles that have been created for use as anthelmintics. Benzimidazoles bind to parasite β-tubulin with high affinity and prevent microtubule polymerization, which disrupts the cytoskeleton and causes the worm to die.[13]

2.    Neuromuscular Mechanisms

The capacity of the majority of parasitic helminths to remain "in situ" in the face of intestinal peristaltic movements or blood or lymphatic flow is essential to their survival in their natural environment. The majority of parasites have specialized sucker-like organs or hooks that allow them to connect to their hosts, or they display well-coordinated rhythmic motions that help them maintain their place within the hosts. Many helminths have a somewhat well-developed neuromuscular system. The subcutaneous muscles of platyhelminths are well-defined and comprise an inner diagonal layer, a middle longitudinal layer, and an outer circular layer. A single layer of muscles made entirely of longitudinal fibres lies under the cuticle of parasitic worms. These muscles' motions are controlled by a rudimentary nervous system made up of nerve fibres and ganglia. Neurotransmitter release is how the nervous system functions. In flagellates, trematodes, and nematodes, acetylcholine and the enzymes that synthesize and hydrolyse it have been shown. Atropine and other cholinergic blocking drugs increase schistosome motor activity, suggesting that acetylcholine has a physiological inhibitory function. This implies that an excitatory transmitter that counteracts acetylcholine's activity is present in these helminths. Schistosome motor activity is noticeably strengthened by 4-alpha-dimethyl-tyramine, tyramine, reserpine, and 5-HT. Several schistosomes have been shown to contain endogenous 5-HT, norepinephrine, and dopamine. Due to disruptions in neurotransmitter function, helminths may exhibit a mild but non-fatal reduction of neuromuscular activity, which might result in muscle incoordination and allow the host defence system to get rid of the parasites. Drugs may operate on sensitive receptors to directly replicate the neurotransmitters' actions. The same result might be obtained by inhibiting the enzymes that break down these neurotransmitters. Conversely, medications may result in a competitive or non-specific inhibition of neurotransmitters. If these effects could be obtained at a level that has little impact on the host, the final outcome would be either the parasite becoming paralyzed or becoming hyperactive. Eserine does not intensify the contraction caused by acetylcholine in the preparation of ascaris nerve muscles. Atropine does not stop this contraction, whereas d-tubocurarine does. Acetylcholine's activity in this tissue is therefore not muscarinic. Acetylcholine relaxes the parasite in liver flukes, which can lead to either total paralysis or a noticeable decrease in contraction amplitude. As a result, not only do the neuromuscular receptors differ across parasites and their hosts, but also amongst helminths.[11]

Examples:

·      Piperazine produces a flaccid, and reversible paralysis of the body wall muscles in Ascaris suum by acting as a mild GABA (4-aminobutyric acid)-mimetic. It is a partial agonist with modest potency at GABA-gated chloride channels, according to single-channel measurements.[13]

·      The unadulterated L-isomer of Tetramisole is levamisole. The worms experience spastic paralysis and muscular spasms as a result of its agonistic effects on nicotinic acetylcholine receptors (nAChRs). Furthermore, levamisole encourages Caenorhabditis elegans (C. elegans) of the wild type to produce eggs.[13]

Other:

·      The genus Streptomyces produces the macrocyclic lactones, such as the avermectin, ivermectin, and abamectin. They have broad-spectrum action against nematodes and can cause a strong and long-lasting paralysis of the pharyngeal and body wall muscles. Only invertebrates, such as nematodes and insects, have glutamate-gated chloride channels, which they selectively agonistically activate. Furthermore, avermectin function as antagonists of nicotinic and GABA receptors that are expressed on parasitic worm somatic muscle cells.[13]

INTRODUCTION TO PLANT BASED ANTHELMINTIC AGENTS

Approximately 80% of people worldwide rely on traditional medicine as their major source of healthcare, according to the WHO. In recent years, there has been a growing scientific and economic interest in the therapeutic species found in natural regions. In between 50,000 and 80,000 blooming plants are utilized medicinally worldwide.[4] Traditional medicine has utilized plants since ancient times. Based on their effectiveness and safety in treating certain conditions, their usage was primarily transmitted orally and later documented in herbal classics. Biologically active substances that mimic pharmaceuticals are what give medicinal plants their therapeutic properties. One important source of new drugs and therapeutic leads is the creation of drugs based on medicinal plants. Numerous drugs derived from medicinal plants have been introduced to the world market, including tiotropium, galantamine, and artemethether. This award was given to the people who discovered ivermectin. In order to avoid detrimental overexploitation of indigenous knowledge and plant species that may have benefits against nematode infections, they promoted "fostering better interaction between traditional healers and scientists."[13] Infections with parasites are significant public health issues. problem, especially in emerging nations where social and economic hardship, unsanitary conditions, the main problem is warm weather. Intestinal parasites harm 3.5 billion individuals worldwide. Intestinal parasite infections accounted for over half a million OPD visits in Ethiopia. One of the most common intestinal parasite illnesses in the nation is taeniasis. Praziquantel and Niclosamide were utilized in conventional medications. Furthermore, for centuries, tapeworm infections have been treated with traditional herbal treatments such Myrsine Africana (Ke chemo), Maesa lanceolata (Kelewa), and Embelia schimperi (Enkoko). Despite the fact that such plants are often used as anthelmintics, there is a dearth of scientifically supported information about efficacy studies, safety studies, phytochemical analyses, and suitable dosage form formulations.[4] The secondary metabolites of medicinal plants are rich sources of potential anthelmintic drugs, and some of the active compounds that have been isolated from these plants have shown anthelmintic efficacy against intestinal worms.[13]

The Rig-Veda lists several plants with various therapeutic purposes, tracing the history of plant medicine in India from 3500 to 1800 B.C. Nonetheless, the great bulk of information on the topic has also been passed down via legend that continues in a number of civilizations. In vitro tests on earthworms have shown that the essential oil of the Piper betle (Piperaceae) possesses anthelmintic properties. According to anthelmintic research, the essential oils of Zanthoxylum alatum (Rutaceae), Cymbopogon nardus (Graminaceae), and C. citratus (Graminaceae) show moderate activity against earthworms, although the oil of the C. nardus has a very good impact. Researchers have often hypothesized that compounds that kill and/or are poisonous to earthworms may also have comparable properties in parasitic worms, which may cause the worms to withdraw from the host, based only on the physical similarities between parasitic roundworms and earthworms.[17]

Nevertheless, in subsequent years, helminth parasites belonging to all three main classes were used as test subjects to assess how effective plants were as anthelmintics. The test parasites that have been employed more commonly to assess the effectiveness of anthelmintic. The plants that are easily obtained from domestic animals that have been slaughtered locally include parasitic species like Ascaris suum, Ascaridia galli, Seteria, Haemonchus contortus, Trichinella spiralis, Taenia spp., Hymenolepis diminuta, Raillietina echinobothrida, Fasciola hepatica, Fasciolopsis buski, Gasthrothylax cruminifer, and Paramphistomum spp. [17]

PLANT EXTRACT AS A SOURCE OF NEW ANTHELMINTIC COMPOUNDS

For many years, plant extracts have been utilized to treat human and animal diseases. For example, the poppy (Papaver somniferous) was said to have analgesic properties 4,000 years ago. Remarkably, the WHO found that up to two to three percent of people worldwide get their primary medical treatment from plants. Before the 19th century, the use of medicinal plants to treat a wide range of ailments was based more on experience than on scientific knowledge. Reasonable drug development started in the 19th century with the isolation of the analgesic morphine. Approximately 25% of prescription medications are derived from plants or their secondary metabolites, and between 50,000 and 70,000 plant species are utilized in Western and traditional medicine. A wide range of chemicals with distinct metabolic functions are produced by plants. Natural compounds made from plant extracts, as opposed to manufactured ones, cam show a variety of variation and frequently offer particular biological activity. Many regions of the world continue to employ medicinal herbs, which have been used for thousands of years to treat parasitism.[14]

Research on the characterisation of active composites and scientific basis for the use of medicinal plant extracts against helminth parasites in people and cattle are still lacking. Anthelmintic resistance has been the subject of several investigations, particularly in tiny ruminants. Based on field management approaches, the faecal egg count reduction test (FECRT) has been utilized in the majority of research. Yet, in vivo drug effectiveness tests have been carried out in highly economically significant regions. Sheep have been the subject of more research than other livestock animals, and a wide range of treatments have previously been created for them. Molecular methods are effective in identifying parasitic nematodes and anthelmintic resistance, and they hold promise for both in vitro and in vivo diagnosis of a number of diseases. Ultimately, reducing parasite drug resistance to anthelmintic drugs will be made easier with a knowledge of the causes of resistance. Using molecular approaches to diagnose medication resistance linked to genetic alterations will assist prevent needless treatments and hence lessen health consequences. On the other hand, using natural plant chemicals may be an additional control strategy that can lessen reliance on medication therapy and postpone the emergence of resistance.[15]

SECONDARY METABOLITES OF PLANTS HAVING ANTHELMINTIC ACTIVITY

All plants generate allelochemicals, and primary metabolites serve as building blocks for various secondary metabolites. Alkaloids, terpenes, flavonoids, resins, and phenolic chemicals are examples of secondary metabolites that give many plants their colour, flavour, and scent.[18]

Using the widely used precipitation and colouring procedure to identify the main natural chemical groups and secondary metabolites found in the plants, phytochemical screening was performed to evaluate the qualitative chemical composition of crude extracts. To detect the phytochemicals of the therapeutic plants, a variety of techniques were combined. To identify the contents as specified by, baseline screening tests were performed on the alcoholic extracts of herbs using a regular procedure and reagents. Flavonoids, Glycosides, Alkaloids, Phenolic compounds, Phlobatannins, Steroids, Saponins, Tannins, and Terpenoids are among the bioactive substances that were screened for in order to find those that were thought to have nematocidal properties.[19] Adding Phyto biotics to animal diets promotes better immunity, boosts nutrient absorption, preserves gut integrity, accelerates development, and reduces diarrheal illness. One substituted phenolic ring is what is referred to as the simplest type of phytochemical. phytochemicals with bioactivity. The chemicals generated from phenylpropane are made up of the highest oxidation states, caffeic and cinnamic acids. It has been shown that the high caffeic acid content in tarragon and thyme herbs helps fight off germs, fungus, and viruses. Pyrogallol and catechol are classified as hydroxylated phenols, which are harmful to several microbes.[20]

·         Terpenes: The mixture of several isoprene units is known as terpenes (C5H8). It exhibits anthelmintic properties that harm the parasite's digestive tract. Examples include borneol, β-element, and terpinen-4-ol, which demonstrated action against H. contortus by preventing egg hatching. Ter-penes with anthelmintic properties.[18]

·         Glycosides: Strong anti-helminth qualities are exhibited by glycosides. Cardenolide causes helminth death by interfering with the flow of potassium and sodium ions into helminths.[18]

·         Saponins: Saponins are composed of sugar chains and triterpene or occasionally steroidal-aglycone. By preventing acetylcholinesterase, saponins exhibit their anthelmintic properties, paralyzing worms and ultimately killing them. Haemonchus contortus and other animal parasitic nematodes are said to be inhibited by them. β-Sitosterol's IC50 value was 58 µM. [18]

·         Flavonoids: Flavonoids aid in auxin transport inhibition, allelopathy, floral coloration, and UV protection. Plants that contain flavonoids exhibit activity by preventing the phosphorylation process, which stops the parasitic worms from producing energy and ultimately kills them. At 10 mg/mL, quercetin caused paralysis in 2.23 ± 4.51 minutes.[18]

·         Tannins: Water-soluble, polyphenolic compounds called tannins aid in the death of nematodes by preventing the worms from absorbing nutrients from the host cell46 or by binding to the parasitic worms' intestinal mucosa and causing autolysis when the larvae consume the condensed tannins. The IC50 value for epigallocatechin was 49 µM. [18]

·         Alkaloids: By inhibiting glucose absorption and targeting the cholinergic receptor, alkaloids have demonstrated anthelmintic action, causing helminths to starve to death. Sanguinarine had an IC50 of 58 µM, whereas dicentrine had an EC90 of 6.3 µg/mL.[18]

·         Phenolic: Phenolic compounds have an aromatic ring that is joined to a functional heterogeneous group. Phenolic chemicals include groups like as flavonoids, iso flavonoids, and tannins that exhibit action via altering the phosphatase enzyme in the helminth's tegument.[18]

·         Non-Protein amino acids: Nitrogen-containing substances with ammonia derivatives and hydrogen atoms are known as non-protein amino acids. They harm parasitic worms by interfering with their central nervous system, which causes paralysis and ultimately death. The IC50 value for mimosine was 16.8 µM. Amino acids that are not proteins but have anthelmintic properties.[18]

Phytochemical screening Methods

EVIDENCE FROM IN-VITRO AND IN-VIVO STUDIES

Before diagnosing an Arthropod (AR) diagnosis, consider several factors. Various diseases may show signs resembling parasitism, and nematodes may not be controlled by anthelmintic therapies due to other reasons. Inaccurate body weight assessment or defective drenching equipment can cause failure. The need for reliable detection techniques has increased, and AR is detected and tracked using both in vitro and in vivo methods. [21]

In vitro Anthelmintics Assay:

The Larval Development test and Egg Hatch Test were used to evaluate several extracts for anthelmintic properties on the two distinct life-cycle stages of H. contortus. In every test, the eggs were extracted from the excrement of donor sheep that had parasite infections.[22]

Egg Hatch Assay:

Guidelines set forth by the World Association for the Advancement of Veterinary Parasitology were followed when collecting the donor sheep's eggs and performing EHA. From the excrement of contaminate donor sheep, the parasites eggs were extracted, crushed in water, and then sifted in stages (500, 250,125, 63, 50, and sieves of 30 mm), and centrifuged at 3000 rpm for 15 minutes. Following a thorough washing with distilled water and then sterilized water, the floating eggs were removed by putting the supernatant into a 32-mm filter. The active therapy consisted of several plant material solvent extracts. Untreated eggs in water served as the negative control, while albendazole served as the positive control. Five millilitre test tubes were used for the experiment. Each test tube included 100 200 eggs and 0.5 cc of water for the assay. To create concentrations of 50, 25, 12.5, 6.2, and 3.13mg/ml, distilled water was added to a total volume of 0.5 ml containing a serial quantity of each plant extract. The water also included eggs. Albendazole was first employed at concentrations of 0.125, 0.063, 0.0313, 0.0156, and 0.0078 mg/ml after being dissolved in DMSO. After that, the test tubes were covered and maintained at 27 C for 48 hours. To prevent additional hatching, a drop of Lugol's iodine solution was added to each test tube. For every concentration, three copies of the experiment were carried out. dead or living larvae that have hatched and after that, the number of unhatched eggs was counted using a dissecting microscope set at 40 magnifications.[22]

Larval development Test:

Since the majority of anthelmintics have some influence on a parasite's metabolism, their effects on parasite development may be useful indicators of resistance. An LDT that involved culturing first-stage larvae to third-stage larvae in the presence of heat was described. both the anthelmintic being tested and lyophilized Escherichia coli as a food source. Appropriate controls were also conducted without anthelmintic. The test detected a strain of H. contortus that was resistant to levamisole and was able to clearly distinguish between strains that were susceptible and resistant to benzimidazole. It was determined that any anthelmintic to which resistance was hypothesized might be used for the test. It was thought to be quick, dependable, affordable, and appropriate for use in anthelmintic resistance field research. Additionally, underdeveloped eggs or fresh faecal samples were not prerequisites for the test because it just needed first stage larvae. The Ivermectin resistance was also found using this technique. Taylor (1990) described a variant of this test that uses yeast extract as a food source. The LDT has been used in surveys for anthelmintic resistance in the UK and has been reported to be reliable in detecting both benzimidazole and levamisole resistance but not ivermectin resistance, despite the fact that it did not provide reliable dose-response lines to determine LD50 (Larval 50% death) values. A microtitre plate experiment, which involves adding nematode eggs to a Nutrient Agar containing the anthelmintic, is one of the additional LDT adaptations. The application of agar was said to resolve avermectin solubility issues and resulted in the calculation of ivermectin dose-response and LD50 values.[24]

Larval Motility Test:       

Three larvae are incubated in different medication doses for twenty-four hours at 25°C in the dark. To excite those who are not paralyzed, they are then disclose to a light for 20 minutes. The percentage of nonmotile larvae in relation to all worm present at each medication concentration is then determined.[21]

Faecal Egg Count Reduction Test (FECRT)

By comparing faecal eggs, the FECRT estimates the effectiveness of anthelmintic treatments.
numbers of animals both prior to and following treatment. There are now guidelines that provide specific information and suggestions on how to use the FECRT.[24]

HOW TRADITIONAL KNOWLEDGE CONTRIBUTES TO MODERN DRUG DEVELOPMENT

The creation of anthelmintic medications has been the subject of more study, but the quest for novel pharmacological agents with novel mechanisms of action is still ongoing. Poor comprehension of the complex life cycles, parasite quantification methods for efficient screening, and the capacity to create efficient models that accurately depict the target parasite's full life cycle are some of the main obstacles in the development of anthelminthic medications. Furthermore, there is debate regarding the necessity of using experimental animals due to the hosts' propensity for variety or specificity. Even while many biological processes can be replicated in experimental models, it is still challenging to achieve comparable outcomes in diseased hosts. The availability of medicinal plants, which may be limited to remote places and necessitate cooperation with indigenous populations, presents a unique obstacle for research into traditional medicines. Better collaborations, however, may provide indigenous groups the chance to create new avenues for their economic growth through the production and harvesting of biologically significant plant species. Nowadays, most anthelmintic treatments and drug development focus on the adult parasite stages and larvae that are isolated from the vectors. Because some of these crucial parasitic stages are difficult to gather in large quantities, researchers are often compelled to use the more easily accessible stages, which may not accurately represent the true parasite stage in the host environment. Therefore, it is unknown how plant-based drugs impact the parasite's actual life cycle stages.[26]

Drug development using medicinal plants continues to be a major source of new drugs and treatment ideas. Numerous drugs derived from medicinal plants have been introduced to the world market, including tiotropium, galantamine, and artemethether. Interestingly, Artemisia annua was awarded the 2015 Nobel Prize in Physiology or Medicine for discovering artemisinin, an antimalarial drug used in traditional Chinese medicine. The individuals who made the discovery of ivermectin received this honour.[27]

An intriguing strategy for interacting at several binding sites and potentially producing additive or synergistic effects is the combination of terpenes with synthetic anthelmintic compounds. Mixed function oxidases from the cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) families extensively metabolize albendazole (ABZ), a benzimidazole methylcarbamate derivative, in the liver. The parent drug undergoes a two-step sulphoxidation process that involves both enzyme pathways, producing the metabolites ABZ sulphoxide (ABZSO) and sulphone (ABZSO2). The anthelmintic action of ABZ is significantly decreased as a result of this sequential metabolism. Consequently, interactions with liver metabolism may result in modifications to the kinetic behaviour of active benzimidazole metabolites. In sheep liver microsomes, TML has recently been shown to inhibit hepatic metabolism that is both CYP1A1-dependent and FMO-mediated. Since both pathways are involved in ABZ S-oxygenation, the monoterpene also prevented the anthelmintic from being metabolized in the liver. The current study aimed to evaluate the pharmaco-chemical interaction in laboratory tests and within the living organisms, as well as the in vivo efficacy of TML and ABZ, in lambs that developed a spontaneous infection with resistant gastrointestinal worms.[25]

CONCLUSION

The combination of plant-based remedies and modern drugs could offer a more effective and sustainable approach to treating parasitic worm infections. While modern drugs are reliable and well-researched, plants provide a natural alternative with fewer side effects. Using both may help tackle parasitic infections in different ways, possibly reducing the risk of drug resistance that can develop with the overuse of synthetic drugs.

For example, plants may enhance the effects of modern drugs or help treat mild infections when pharmaceutical drugs are not available. Additionally, plant-based treatments could complement the action of drugs by supporting overall health or managing side effects. Research into combining these approaches could lead to more affordable, accessible, and effective treatments, especially in areas with limited access to modern medications or where resistance to drugs is becoming a concern.

REFERENCES

1.      Dereje Tulu Robi, Tesfa Mossie & Shiferaw Temteme. (2023) Eukaryotic Infections in Dairy Calves: Impacts, Diagnosis, and Strategies for Prevention and Control. Veterinary Medicine: Research and Reports 14, pages 195-208.

2.      Delfin E. Cabardo Jr., Harvie P. Portugaliza. (2017) Anthelmintic activity of Moringa oleifera seed aqueous and ethanolic extracts against Haemonchus contortus eggs and third stage larvae. International Journal of Veterinary Science and Medicine, Pages 30-34, doi.org/10.1016/j.ijvsm.2017.02.001

3.      Mbuh, J. V., & Nembu, N. E. (2012). Malnutrition and intestinal helminth infections in schoolchildren from Dibanda, Cameroon. Journal of Helminthology, 87(01), 46–51. doi:10.1017/s0022149x12000016

4.      Feyisa Kuma, Tadesse Birhanu* and Eyob Hirpa. (2015) Advanced Review on Anthelmintic Medicinal Plants. School of Veterinary Medicine, College of Medical and Health Sciences, Wollega University, P.O. Box 395, Nekemte, Ethiopia.

5.      Imhoff-Kunsch, B., & Briggs, V. (2012). Antihelminthics in Pregnancy and Maternal, Newborn and Child Health. Paediatric and Perinatal Epidemiology, 26, 223–238. doi:10.1111/j.1365-3016.2012.01280.x 

6.      Romero-Benavides, J. C., Ruano, A. L., Silva-Rivas, R., Castillo-Veintimilla, P., Vivanco-Jaramillo, S., & Bailon-Moscoso, N. (2017). Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies. European Journal of Medicinal Chemistry, 129, 209–217. doi:10.1016/j.ejmech.2017.02.005 

7.      Abongwa, M., Martin, R. J., & Robertson, A. P. (2017). A brief review on the mode of action of antinematodal drugs. Acta Veterinaria, 67(2), 137–152. doi:10.1515/acve-2017-0013 

8.      Lindy Holden-Dye and Robert J. Walker. (June 25, 2005), WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.7.1, http://www.wormbook.org.

9.      PIYUSH YADAV*, RUPALI SINGH. (2011), A Review on Anthelmintic drugs and their future scope, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 3.

10.  Bossche, H. V. (1985). Pharmacology of Anthelmintics. Handbook of Experimental Pharmacology, 125–181. doi:10.1007/978-3-642-69527-8_4

11.  Sheth, U. K. (1975). Mechanisms of Anthelmintic Action. Progress in Drug Research / Fortschritte Der Arzneimittelforschung / Progrès Des Recherches Pharmaceutiques, 147–157. doi:10.1007/978-3-0348-7090-0_19  

12.  REW, R. S. (1978). Mode of action of common anthelmintics. Journal of Veterinary Pharmacology and Therapeutics, 1(3), 183–197. doi:10.1111/j.1365-2885.1978.tb00326.x

13.  Liu, M., Panda, S. K., & Luyten, W. (2020). Plant-Based Natural Products for the Discovery and Development of Novel Anthelmintics against Nematodes. Biomolecules, 10(3), 426. https://doi.org/10.3390/biom10030426

14.  Jayawardene, K. L. T. D., Palombo, E. A., & Boag, P. R. (2021). Natural Products Are a Promising Source for Anthelmintic Drug Discovery. Biomolecules, 11(10), 1457. https://doi.org/10.3390/biom11101457

15.  Ahmed, H., Kilinc, S. G., Celik, F., Kesik, H. K., Simsek, S., Ahmad, K. S., Afzal, M. S., Farrakh, S., Safdar, W., Pervaiz, F., Liaqat, S., Zhang, J., & Cao, J. (2023). An Inventory of Anthelmintic Plants across the Globe. Pathogens, 12(1), 131. https://doi.org/10.3390/pathogens12010131

16.  Samantha A. Nixon, Claudia Welz , Debra J. Woods , Livio Costa-Junior , Mostafa Zamanian , Richard J. Martin. (2020), Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics. International Journal for Parasitology: Drugs and Drug Resistance. Volume 14, Pages 8-16, https://doi.org/10.1016/j.ijpddr.2020.07.001

17.  V. Tandon, A. K. Yadav, B. Roy and B. Das. (2011), Phytochemicals as cure of worm infections in traditional medicine systems, Emerging Trends in Zoology, Pages 351–378

18.  Adak, M., & Kumar, P. (2022). Herbal anthelmintic agents: a narrative review. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 42(4), 641–651. https://doi.org/10.19852/j.cnki.jtcm.2022.04.007

19.  Hassen Shamil Mumed, Dereje Regassa Nigussie, Kedir Sali Musa, Abdallahi Abdurahman Demissie. (2022), In Vitro Anthelmintic Activity and Phytochemical Screening of Crude Extracts of Three Medicinal Plants against Haemonchus Contortus in Sheep at Haramaya Municipal Abattoir, Eastern Hararghe, journal of parasitology research, https://doi.org/10.1155/2022/6331740

20.   Ahmad S, Humak F, Ahmad M, Altaf H, Qamar W, Hussain A, Ashraf U, Abbas RZ, Siddique A, Ashraf T and Mughal MAS, 2023. Phytochemicals as alternative anthelmintics against poultry parasites: A review. Agrobiological Records 12: 34-45. https://doi.org/10.47278/journal.abr/2023.015

21.  Fissiha, W., & Kinde, M. Z. (2021). Anthelmintic Resistance and Its Mechanism: A Review. Infection and Drug Resistance, 14, 5403–5410. https://doi.org/10.2147/IDR.S332378

22.  Kamaraj, C., & Rahuman, A. A. (2011). Efficacy of anthelmintic properties of medicinal plant extracts against Haemonchus contortus. Research in Veterinary Science, 91(3), 400–404. doi:10.1016/j.rvsc.2010.09.018

23.  Delfin E. Cabardo Jr., Harvie P. Portugaliza. (2017), Anthelmintic activity of Moringa oleifera seed aqueous and ethanolic extracts against Haemonchus contortus eggs and third stage larvae, International Journal of Veterinary Science and Medicine. Volume 5, Issue 1, page no 30-34, https://doi.org/10.1016/j.ijvsm.2017.02.001

24.  Taylor, M. A., Hunt, K. R., & Goodyear, K. L. (2002). Anthelmintic resistance detection methods. Veterinary Parasitology, 103(3), 183–194. doi:10.1016/s0304-4017(01)00604-5

25.  María Victoria Miró a, Carolina Rocha e Silva c, Paula Viviani a, Sonia Luque b, Mercedes Lloberas b, Livio Martins Costa-Júnior c, Carlos Lanusse a, Guillermo Virkel a, Adrián Lifschitz. (2020), Combination of bioactive phytochemicals and synthetic anthelmintics: In vivo and in vitro assessment of the albendazole-thymol association, Veterinary Parasitology. Volume 281, https://doi.org/10.1016/j.vetpar.2020.109121

26.  Jayawardene, K. L. T. D., Palombo, E. A., & Boag, P. R. (2021). Natural Products Are a Promising Source for Anthelmintic Drug Discovery. Biomolecules, 11(10), 1457. https://doi.org/10.3390/biom11101457

27.  Liu, M., Panda, S. K., & Luyten, W. (2020). Plant-Based Natural Products for the Discovery and Development of Novel Anthelmintics against Nematodes. Biomolecules, 10(3), 426. https://doi.org/10.3390/biom10030426